Experts Highlight Crucial Difference Between Preventing and Treating Postpartum Hemorrhage
Researchers clarify that while tranexamic acid is a proven emergency treatment for heavy bleeding after childbirth, evidence does not support using it as a universal preventive measure.
Key points
- Tranexamic acid is an effective, lifesaving treatment when given promptly after postpartum hemorrhage is diagnosed.
- Evidence from the WOMAN trial supports acute treatment but does not justify routine preventive use.
- Researchers warn against adopting universal prophylactic protocols without dedicated clinical trial evidence for prevention.
Medical researchers responding to academic commentary in The Lancet have emphasized the essential distinction between treating and preventing postpartum hemorrhage. While reaffirming that tranexamic acid is a critical therapeutic drug when severe bleeding occurs after childbirth, the authors cautioned against using treatment evidence to justify routine preventive administration.
The response addressed communications from researchers Judith Lieber, Gabriele Saccone, and their colleagues concerning a broader series on maternal health. The authors cited data from the landmark WOMAN trial, which demonstrated that prompt administration of tranexamic acid after a postpartum hemorrhage diagnosis provides clear clinical benefits. However, they noted that success in acute treatment settings must not be interpreted as proof of preventive effectiveness.
The authors specifically warned against using therapeutic data to recommend universal drug prophylaxis for postpartum bleeding in countries with a high burden of maternal mortality. They emphasized that clinical policies must distinguish between managing an established emergency and applying preventative interventions across entire patient populations.
What to know: Postpartum hemorrhage remains a leading cause of maternal mortality worldwide. While prompt medication following diagnosis saves lives, individual care strategies depend on accurate clinical evaluation. Patients should consult their healthcare providers regarding childbirth safety plans and hemorrhage risk management.
Source The Lancet — thelancet.com/journals/lancet/article/PIIS0140-6736(26)01981-1/full… ↗
Read next
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
🧠AI AnalysisUltraprocessed Diets May Impact Brain Reward Systems in Younger Adults
A Virginia Tech study suggests that individuals aged 18 to 21 may experience changes in brain reward processing after consuming ultraprocessed foods, a response not obser…
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.